Posted in | News | Plastics and Polymers

Solvay Plan to Increase Vinyl Production in Brazil

Solvay announces today that the Board of its affiliate Solvay Indupa has approved a USD 150 million investment program to expand and modernize its vinyls production plant of Santo Andre, Brazil, in anticipation of rapidly growing demand in Latin America.

The investment program includes upgrading the plant’s electrolysis unit through the implementation of modern membrane technology with a nameplate annual capacity of 150,000 metric tons of chlorine and the expansion of the downstream vinyl chloride monomer (VCM) and polyvinyl chloride (PVC) manufacturing facility, with the installation of larger, more competitive equipment. As a result, by the end of 2008, the Santo Andre plant will have a total annual VCM and PVC production capacity of 300,000 metric tons, with world-class, state-of-the-art installations. Subsequent developments will be considered to further expand the plant, whose fully integrated PVC capacity could be easily lifted in line with the demand growth .

“Solvay is implementing a consistent strategy of sustainable and profitable growth, feeding on geographical expansion and constant improvements to stay at the leading edge of competitiveness,” commented Jacques van Rijckevorsel, General Manager of the Plastics Sector, Solvay. “This sizeable investment in Brazil lies within the scope of our strategy and reflects the high growth of Latin American economies, which is boosting demand for products from the vinyls chain,” added Jacques van Rijckevorsel.

The Solvay group is one of the world’s leading vinyls producer, ranking second in Europe and third globally. In addition to SolVin, its joint venture with BASF in Europe, the Group’s activities in PVC and other products of the vinyl chain span across Asia and Latin America, through the affiliates Vinythai in Thailand and Solvay Indupa in Argentina and Brazil.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.